Dimensional Fund Advisors’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.28M Buy
2025
Q2
$942K Buy
2023
Q3
Sell
2023
Q2
$485K Buy
2023
Q1
$217K Buy
2022
Q4
$147 Buy
2022
Q3
$64K Buy